AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 259 filers reported holding AMICUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $9,251,000 | +63.1% | 400,650 | -0.3% | 0.66% | +49.7% |
Q3 2020 | $5,673,000 | -6.4% | 401,793 | -0.0% | 0.44% | +6.8% |
Q2 2020 | $6,060,000 | +63.2% | 401,883 | -0.0% | 0.41% | +38.6% |
Q1 2020 | $3,714,000 | -5.6% | 401,983 | -0.5% | 0.30% | +16.0% |
Q4 2019 | $3,936,000 | +17013.0% | 404,129 | +23588.7% | 0.26% | +12750.0% |
Q1 2019 | $23,000 | +43.8% | 1,706 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $16,000 | -62.8% | 1,706 | -52.0% | 0.00% | -66.7% |
Q3 2018 | $43,000 | -28.3% | 3,551 | -7.9% | 0.00% | -25.0% |
Q2 2018 | $60,000 | -4.8% | 3,857 | -8.0% | 0.00% | 0.0% |
Q1 2018 | $63,000 | -96.4% | 4,193 | -96.5% | 0.00% | -95.5% |
Q4 2017 | $1,746,000 | -4.5% | 121,303 | +0.1% | 0.09% | +17.3% |
Q3 2017 | $1,828,000 | – | 121,219 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |